AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 79 filers reported holding AKCEA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $696,000 | +49.7% | 38,334 | +12.9% | 0.00% | – |
| Q2 2020 | $465,000 | +80.9% | 33,946 | +88.7% | 0.00% | – |
| Q1 2020 | $257,000 | -17.6% | 17,994 | -2.7% | 0.00% | – |
| Q4 2019 | $312,000 | +30.0% | 18,486 | +18.6% | 0.00% | – |
| Q3 2019 | $240,000 | +27.7% | 15,591 | +94.3% | 0.00% | – |
| Q2 2019 | $188,000 | -37.7% | 8,023 | -25.0% | 0.00% | – |
| Q1 2019 | $302,000 | +56.5% | 10,694 | +67.1% | 0.00% | – |
| Q4 2018 | $193,000 | -96.6% | 6,400 | -96.0% | 0.00% | -100.0% |
| Q3 2018 | $5,666,000 | +1566.5% | 161,781 | +1026.2% | 0.00% | – |
| Q2 2018 | $340,000 | +17.2% | 14,365 | +27.0% | 0.00% | – |
| Q1 2018 | $290,000 | +607.3% | 11,312 | +375.7% | 0.00% | – |
| Q4 2017 | $41,000 | +310.0% | 2,378 | +583.3% | 0.00% | – |
| Q3 2017 | $10,000 | – | 348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |